335 related articles for article (PubMed ID: 6665563)
1. Clinical trials: a recent emphasis in the prevention program of the National Cancer Institute.
DeWys WD; Greenwald P
Semin Oncol; 1983 Sep; 10(3):360-4. PubMed ID: 6665563
[No Abstract] [Full Text] [Related]
2. Clinical research. No lifeline for proposed breast cancer prevention trial.
Kaiser J
Science; 2007 Jun; 316(5832):1679. PubMed ID: 17588904
[No Abstract] [Full Text] [Related]
3. Clinical development of anticancer agents--a National Cancer Institute perspective.
Marsoni S; Wittes R
Cancer Treat Rep; 1984 Jan; 68(1):77-85. PubMed ID: 6362870
[No Abstract] [Full Text] [Related]
4. Report of the Cancer Chemotherapy Collaborative Program Review Committee: the Richardson report. June 1966, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Cancer Treat Rep; 1984 Jan; 68(1):343-56. PubMed ID: 6692435
[No Abstract] [Full Text] [Related]
5. National Cancer Institute--supported cancer chemoprevention research: coming of age.
McCaskill-Stevens W; Hawk ET; Flynn PJ; Lippman SM
J Clin Oncol; 1999 Nov; 17(11 Suppl):53-62. PubMed ID: 10630263
[No Abstract] [Full Text] [Related]
6. NCI's transition plan for participants in women's health trial.
Oncology (Williston Park); 1988 Dec; 2(12):36. PubMed ID: 3079290
[No Abstract] [Full Text] [Related]
7. NCI cancer prevention and control research.
Greenwald P
Prev Med; 1993 Sep; 22(5):642-60. PubMed ID: 8234204
[TBL] [Abstract][Full Text] [Related]
8. Screening at the National Cancer Institute.
Goldin A; Venditti JM; Carter SK
Natl Cancer Inst Monogr; 1977 Mar; (45):37-48. PubMed ID: 337155
[No Abstract] [Full Text] [Related]
9. NIH Consensus Development Conference summary: Adjuvant Chemotherapy of Breast Cancer.
J Tenn Med Assoc; 1981 Mar; 74(3):190-2. PubMed ID: 7024644
[No Abstract] [Full Text] [Related]
10. As memory serves--an informal history of the National Cancer Institute, 1937-57.
Shimkin MB
J Natl Cancer Inst; 1977 Aug; 59(2 Suppl):559-600. PubMed ID: 328903
[No Abstract] [Full Text] [Related]
11. Cancer research. Budget pressure puts high-profile study in doubt.
Marshall E
Science; 2007 Mar; 315(5818):1477. PubMed ID: 17363634
[No Abstract] [Full Text] [Related]
12. Cancer institute to tighten control of trials.
Gavaghan H
Nature; 1994 Apr; 368(6473):679. PubMed ID: 8152474
[No Abstract] [Full Text] [Related]
13. The role of the National Cancer Institute in drug development.
Doroshow J
Clin Adv Hematol Oncol; 2005 Apr; 3(4):257-8. PubMed ID: 16166997
[No Abstract] [Full Text] [Related]
14. Role of diet and nutrition in cancer cause, prevention and treatment.
Gori GB
Bull Cancer; 1978; 65(2):115-26. PubMed ID: 359068
[TBL] [Abstract][Full Text] [Related]
15. Breast Cancer Prevention Trial shows major benefit, some risk.
Jpn J Clin Oncol; 1998 Jun; 28(6):417-8. PubMed ID: 9730162
[No Abstract] [Full Text] [Related]
16. Investigational trials of anticancer drugs: establishing safeguards for experimentation.
Chabner BA; Wittes R; Hoth D; Hubbard S
Public Health Rep; 1984; 99(4):355-60. PubMed ID: 6431482
[TBL] [Abstract][Full Text] [Related]
17. Diet, nutrition and cancer. National Cancer Institute.
Conn Med; 1980 Nov; 44(11):717-20. PubMed ID: 6262011
[No Abstract] [Full Text] [Related]
18. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
Greenwald P
J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
[TBL] [Abstract][Full Text] [Related]
19. Technology evaluation: CC49 humanized radioimmunoconjugates, National Cancer Institute.
Sheikh N
Curr Opin Mol Ther; 2003 Aug; 5(4):428-32. PubMed ID: 14513687
[TBL] [Abstract][Full Text] [Related]
20. Community Clinical Oncology Program participation in the Breast Cancer Prevention Trial: factors affecting accrual.
Klabunde C; Kaluzny A; Ford L
Cancer Epidemiol Biomarkers Prev; 1995; 4(7):783-9. PubMed ID: 8672997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
